NCT07708870 Nurse-Led Caregiver Support for Older Adults With Advanced Lung Cancer
| NCT ID | NCT07708870 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Non-Small Cell Lung Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-04-08 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-04-08 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This two-phase study aims to examine the current status of older adults with newly diagnosed locally advanced or advanced non-small cell lung cancer and their primary family caregivers, and to evaluate the effects of the Integrating Nurse-Led and Resource Utilization-Based Caregiver Support Model (ICSM). Phase I is a cross-sectional correlational study assessing distress, unmet care needs, resource awareness and utilization, social support, and health promotion practice. Phase II is a two-group randomized controlled trial comparing ICSM plus oncology case manager care with oncology case manager care and usual hospital care. The intervention includes nurse-led education and counseling, symptom management, emotional coping, problem-solving, social resource use, caregiving activity arrangement, and use of a web-based or LINE-based integrated resource system.
Eligibility Criteria
Inclusion Criteria: Patient inclusion criteria: * Older adults with newly diagnosed locally advanced or advanced non-small cell lung cancer. * Stage III or stage IV non-small cell lung cancer. * Aware of their cancer diagnosis. * Preparing to receive anti-cancer medical treatment. * Able to communicate verbally and complete study assessments. * Willing to participate in the study and provide written informed consent. Caregiver inclusion criteria: * Adult aged 18 years or older. * Identified by the eligible patient as the fixed primary family caregiver. * Able to participate in the study together with the patient as a patient-caregiver dyad. * Willing to participate in the study and provide written informed consent. Exclusion Criteria: Patient exclusion criteria: \- Severe cognitive impairment that prevents completion of study questionnaires or assessments. Caregiver exclusion criteria: * Unable to communicate sufficiently to complete study assessments. * Unable or unwilling to provide written informed consent.
Frequently Asked Questions
Who can join the NCT07708870 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Non-Small Cell Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07708870 currently recruiting?
Yes, NCT07708870 is actively recruiting participants. Visit ClinicalTrials.gov or contact National Taiwan University Hospital to inquire about joining.
Where is the NCT07708870 trial being conducted?
This trial is being conducted at Taipei, Taiwan, Taipei, Taiwan.
Who is sponsoring the NCT07708870 clinical trial?
NCT07708870 is sponsored by National Taiwan University Hospital. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.